Autoradiographic distribution of 5‐HT7 receptors in the human brain using [3H]mesulergine: comparison to other mammalian species
暂无分享,去创建一个
[1] C. Davies,et al. 5-HT7 receptors modulate synchronized network activity in rat hippocampus , 2002, Neuropharmacology.
[2] R. Pearson,et al. The Human Nervous System. Basic Elements of Structure and Function , 1967, The Yale Journal of Biology and Medicine.
[3] Terrence P. Kenakin,et al. A Pharmacologic Analysis of Drug-Receptor Interaction , 1987 .
[4] J. Hagan,et al. [3H]‐SB‐269970 – A selective antagonist radioligand for 5‐HT7 receptors , 2000 .
[5] J. Plassat,et al. Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. , 1993, Molecular pharmacology.
[6] L. Swanson. The Rat Brain in Stereotaxic Coordinates, George Paxinos, Charles Watson (Eds.). Academic Press, San Diego, CA (1982), vii + 153, $35.00, ISBN: 0 125 47620 5 , 1984 .
[7] R. Andrade,et al. A 5-HT(7) receptor-mediated depolarization in the anterodorsal thalamus. II. Involvement of the hyperpolarization-activated current I(h). , 2001, The Journal of pharmacology and experimental therapeutics.
[8] A. Sleight,et al. Correlation between 5-HT7 receptor affinity and protection against sound-induced seizures in DBA/2J mice , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.
[9] J. Hagan,et al. Characterization of SB‐269970‐A, a selective 5‐HT7 receptor antagonist , 2000, British journal of pharmacology.
[10] D. Sibley,et al. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. , 1994, The Journal of pharmacology and experimental therapeutics.
[11] P. Vincent,et al. Serotonin suppresses the slow afterhyperpolarization in rat intralaminar and midline thalamic neurones by activating 5‐HT7 receptors , 2002, The Journal of physiology.
[12] P P Humphrey,et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.
[13] I. Coupar,et al. Characterisation of a 5-HT(7) binding site in mouse ileum. , 2000, European journal of pharmacology.
[14] T. Branchek,et al. A receptor autoradiographic and in situ hybridization analysis of the distribution of the 5‐ht7 receptor in rat brain , 1996, British journal of pharmacology.
[15] A. Tsou,et al. Cloning and Expression of a 5‐Hydroxytryptamine7 Receptor Positively Coupled to Adenylyl Cyclase , 1994, Journal of neurochemistry.
[16] R. Cone,et al. Cloning and expression of a 5HT7 receptor from Xenopus laevis. , 1995, Receptors & channels.
[17] H. Baumgarten,et al. Serotoninergic Neurons and 5-HT Receptors in the CNS , 2000, Handbook of Experimental Pharmacology.
[18] W. Burkard,et al. Extracts and constituents of Hypericum perforatum inhibit the binding of various ligands to recombinant receptors expressed with the Semliki Forest virus system. , 1999, Journal of receptor and signal transduction research.
[19] T. Kenakin. The classification of drugs and drug receptors in isolated tissues. , 1984, Pharmacological reviews.
[20] M. Wood,et al. Antagonist activity of meta-chlorophenylpiperazine and partial agonist activity of 8-OH-DPAT at the 5-HT(7) receptor. , 2000, European journal of pharmacology.
[21] J. Palacios,et al. 5-HT receptors in mammalian brain: receptor autoradiography andin situ hybridization studies of new ligands and newly identified receptors , 1996, The Histochemical Journal.
[22] Guang-di Yu,et al. The inhibitory effect of serotonin on the spontaneous discharge of suprachiasmatic neurons in hypothalamic slice is mediated by 5-HT7 receptor , 2001, Brain Research Bulletin.
[23] R. Eglen,et al. Characterization and distribution of putative 5‐ht7 receptors in guinea‐pig brain , 1995, British journal of pharmacology.
[24] J. Palacios,et al. Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: evidence for species differences in brain serotonin-2 receptors. , 1984, European journal of pharmacology.
[25] Trevor Sharp,et al. A review of central 5-HT receptors and their function , 1999, Neuropharmacology.
[26] A. Eison,et al. Effects of Antidepressants on 5-HT7 Receptor Regulation in the Rat Hypothalamus , 1999, Neuropsychopharmacology.
[27] D. McCormick,et al. Neurotransmitter actions in the thalamus and cerebral cortex. , 1992, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.
[28] I. Coupar,et al. [3H]‐Mesulergine labels 5‐HT7 sites in rat brain and guinea‐pig ileum but not rat jejunum , 1999, British journal of pharmacology.
[29] A. Closse. [3H]Mesulergine, a selective ligand for serotonin-2 receptors. , 1983, Life sciences.
[30] D. Sibley,et al. Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. , 1993, The Journal of biological chemistry.
[31] S. Ying,et al. 5-HT7 receptors mediate serotonergic effects on light-sensitive suprachiasmatic nucleus neurons , 1997, Brain Research.
[32] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[33] J. Sutcliffe,et al. No hypothermic response to serotonin in 5-HT7 receptor knockout mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[34] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.
[35] T. Branchek,et al. Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. , 1993, The Journal of biological chemistry.
[36] R. Kohen,et al. Four 5‐Hydroxytryptamine7 (5‐HT7) Receptor Isoforms in Human and Rat Produced by Alternative Splicing: Species Differences Due to Altered Intron‐Exon Organization , 1997, Journal of Neurochemistry.
[37] G. Martin,et al. The 5-HT7 receptor: orphan found. , 1997, Trends in pharmacological sciences.
[38] C. Langmead,et al. The effect of SB‐269970, a 5‐HT7 receptor antagonist, on 5‐HT release from serotonergic terminals and cell bodies , 2001, British journal of pharmacology.
[39] M. Erlander,et al. A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms , 1993, Neuron.
[40] H. Saito,et al. Inhibition by 5‐HT7 receptor stimulation of GABAA receptor‐activated current in cultured rat suprachiasmatic neurones. , 1994, The Journal of physiology.
[41] C. Waeber,et al. Autoradiographic visualisation of [3H]5-carboxamidotryptamine binding sites in the guinea pig and rat brain. , 1995, European journal of pharmacology.
[42] J. Hagan,et al. SB‐656104‐A, a novel selective 5‐HT7 receptor antagonist, modulates REM sleep in rats , 2003, British journal of pharmacology.
[43] R. Andrade,et al. A 5-HT7 Receptor-Mediated Depolarization in the Anterodorsal Thalamus. II. Involvement of the Hyperpolarization-Activated Current Ih , 2001 .
[44] S. Beck,et al. 5-Hydroxytryptamine(7) receptor activation decreases slow afterhyperpolarization amplitude in CA3 hippocampal pyramidal cells. , 2000, The Journal of pharmacology and experimental therapeutics.
[45] J. Hankinson. A stereotaxic atlas of the forebrain of the guinea pig , 1968 .
[46] A. Sleight,et al. Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment. , 1995, Molecular pharmacology.
[47] N. Barnes,et al. Selective labelling of 5-HT7 receptor recognition sites in rat brain using [3H]5-carboxamidotryptamine , 1998, Neuropharmacology.
[48] Á. Pazos,et al. Identification and Characterization of a New Serotonergic Recognition Site with High Affinity for 5‐Carboxamidotryptamine in Mammalian Brain , 1997, Journal of neurochemistry.
[49] J. Neumaier,et al. Localization of 5-HT7 receptors in rat brain by immunocytochemistry, in situ hybridization, and agonist stimulated cFos expression , 2001, Journal of Chemical Neuroanatomy.
[50] R. Heavens,et al. Distribution of 5-ht(5A), 5-ht(5B), 5-ht(6) and 5-HT(7) receptor mRNAs in the rat brain. , 2001, Brain research. Molecular brain research.
[51] J. Palacios,et al. The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. , 1984, European journal of pharmacology.
[52] W. Olijve,et al. Human serotonin 5‐HT7 receptor: cloning and pharmacological characterisation of two receptor variants , 1997, FEBS letters.
[53] D. Middlemiss,et al. [3 H]-SB-269970 radiolabels 5-HT7 receptors in rodent, pig and primate brain tissues , 2002, Neuropharmacology.
[54] J. Leysen,et al. 5-HT7 receptors: current knowledge and future prospects. , 2000, Trends in pharmacological sciences.
[55] J. Terrón,et al. Role of 5-HT1A and 5-HT7 receptors in the facilitatory response induced by 8-OH-DPAT on learning consolidation , 2001, Behavioural Brain Research.
[56] P. Szot,et al. Function and distribution of three rat 5-hydroxytryptamine7 (5-HT7) receptor isoforms produced by alternative splicing , 1998, Neuropharmacology.
[57] R. Eglen,et al. Cloning, expression and pharmacology of a truncated splice variant of the human 5‐HT7 receptor (h5‐HT7(b)) , 1997 .
[58] A. Meneses,et al. 5-HT system and cognition , 1999, Neuroscience & Biobehavioral Reviews.
[59] K. Krobert,et al. The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution , 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.
[60] R. Mair,et al. Learning impairments after 6-OHDA treatment: A comparison with the effects of thiamine deficiency , 1986, Behavioural Brain Research.
[61] J. Schwartz,et al. Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[62] Xavier Langlois,et al. Reconsideration of 5-hydroxytryptamine (5-HT)(7) receptor distribution using [(3)H]5-carboxamidotryptamine and [(3)H]8-hydroxy-2-(di-n-propylamino)tetraline: analysis in brain of 5-HT(1A) knockout and 5-HT(1A/1B) double-knockout mice. , 2002, The Journal of pharmacology and experimental therapeutics.